Author:
Cahn P,Altclas J,Martins M,Losso M,Cassetti I,Cooper DA,Cox S
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Reference14 articles.
1. Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2′-deoxy-3′-oxa-4′-thiocytidine;de Muys;Antimicrob Agents Chemother,1999
2. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(±)-2′-deoxy-3′-oxa-4′-thiocytidine, dOTC];Taylor;Antivir Chem Chemother,2000
3. In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs;Bethell;Antivir Chem Chemother,2005
4. In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection;Gu;Antimicrob Agents Chemother,2006
5. Cox S Parkin N Limoli K Coates J. 11th European AIDS Conference
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献